Skip to main content
. 2020 May 8;59(16):1939–1945. doi: 10.2169/internalmedicine.4552-20

Figure 2.

Figure 2.

Computed tomography scan of the chest before pembrolizumab treatment and at the onset of lung injury in a 76-year-old man with pleomorphic carcinoma (a: Case 2), a 78-year-old man with adenocarcinoma (b: Case 3), and an 81-year-old man with adenosquamous carcinoma (c: Case 4).